Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
$NVIDIA (NVDA.US)$ has been the standout tech stock of the past year, leading the $NASDAQ 100 Index (.NDX.US)$ in the performance ranking.
$英偉達 (NVDA.US)$ 一直是過去一年的傑出科技股,領先 $納斯達克100指數 (.NDX.US)$ 在績效排名中。
The chipmaker giant has seen an astounding 186% surge since the end of May 2023, fueled by skyrocketing demand for chips in artificial intelligence development.
自2023年5月底以來,這家芯片製造商巨頭的驚人增長了186%,這得益於人工智能開發中對芯片的需求激增。
Veteran Wall Street investor Ed Yardeni recently coined " Magnificent One" to differentiate Nvidia's extraordinary performance from the Magnificent Seven.
華爾街資深投資人埃德·亞爾德尼最近創造了 “Magnificent One”,以區分Nvidia的非凡表現與壯麗七人組。
To illustrate the magnitude of Nvidia's market value increase, just a year ago, the company was valued at $1 trillion. Today, it boasts a staggering $2.8 trillion valuation, making it the third-largest company in the U.S.
爲了說明Nvidia市值增長的幅度,就在一年前,該公司的估值爲1萬億美元。如今,它擁有驚人的2.8萬億美元估值,使其成爲美國第三大公司。
Nvidia's current value is equal to $Tesla (TSLA.US)$, $Eli Lilly and Co (LLY.US)$, $Broadcom (AVGO.US)$, $Walmart (WMT.US)$ and $MasterCard (MA.US)$ combined.
Nvidia 的當前價值等於 $特斯拉 (TSLA.US)$, $禮來 (LLY.US)$, $博通 (AVGO.US)$, $沃爾瑪 (WMT.US)$ 和 $萬事達 (MA.US)$ 結合的。
However, Nvidia's spectacular ascent is eclipsed by these seven U.S. stocks, which have more than doubled the chipmaker's impressive returns over the last year.
但是,這七隻美國股票使Nvidia的驚人上漲黯然失色,這七隻股票使這家芯片製造商去年可觀的回報率翻了一番多。
7. $Vera Therapeutics (VERA.US)$: 363%
7。 $Vera Therapeutics (VERA.US)$: 363%
$Vera Therapeutics (VERA.US)$ is a biopharmaceutical company dedicated to developing transformative treatments for serious immunological diseases. The company's stock surged due to advancements in its clinical programs and optimistic projections for its drug candidates.
$Vera Therapeutics (VERA.US)$ 是一家生物製藥公司,致力於開發針對嚴重免疫疾病的變革性治療方法。由於臨床項目的進展以及對候選藥物的樂觀預測,該公司的股票飆升。
Its 363% surge since May 30, 2023, doubled the performance of Nvidia during the same timeframe.
自2023年5月30日以來,其增長了363%,使英偉達在同一時期的表現翻了一番。
6. $Vertiv Holdings (VRT.US)$: 413%
6。 $Vertiv Holdings (VRT.US)$: 413%
Vertiv Holdings Co. provides critical digital infrastructure and continuity solutions. The company has benefited from the increasing demand for data centers and IT infrastructure, driving robust financial performance and, consequently, a substantial increase in its stock price.
Vertiv Holdings Co. 提供關鍵的數字基礎設施和連續性解決方案。該公司受益於對數據中心和IT基礎設施不斷增長的需求,推動了強勁的財務業績,從而實現了股價的大幅上漲。
5. $MicroStrategy (MSTR.US)$: 441%
5。 $MicroStrategy (MSTR.US)$: 441%
MicroStrategy Incorporated is a business intelligence company that has gained substantial attention for its significant investments in $Bitcoin (BTC.CC)$.
MicroStrategy Incorporated是一家商業智能公司,因其在以下方面的重大投資而備受關注 $比特幣 (BTC.CC)$。
The company's stock performance is closely tied to Bitcoin's price movements, and its value has soared with the cryptocurrency's rise. The largest cryptocurrency has seen a 140% rise since the end of May 2023.
該公司的股票表現與比特幣的價格走勢密切相關,其價值隨着加密貨幣的上漲而飆升。自2023年5月底以來,最大的加密貨幣已上漲140%。
4. $Abercrombie & Fitch (ANF.US)$: 503%
4。 $愛芬奇 (ANF.US)$: 503%
Abercrombie & Fitch is a renowned fashion retailer, known for its casual wear and lifestyle products. The stock's impressive rise is attributed to the company's successful rebranding efforts, strong e-commerce growth and improved profitability metrics, attracting investor interest.
Abercrombie & Fitch是一家著名的時裝零售商,以其休閒服裝和生活方式產品而聞名。該股的驚人上漲歸因於該公司成功的品牌重塑工作、強勁的電子商務增長和盈利指標的改善,吸引了投資者的興趣。
3. $Carvana (CVNA.US)$: 666%
3。 $Carvana (CVNA.US)$: 666%
Carvana is an online used car retailer that has revolutionized the car buying experience by offering a fully online platform with home delivery and a seven-day return policy.
Carvana是一家在線二手車零售商,通過提供送貨上門和七天退貨政策的完全在線平台,徹底改變了購車體驗。
Its stock skyrocketed as the company continued to recover from a difficult period and investors regained confidence in its unique business model and growth potential.
隨着公司繼續從困難時期中恢復過來,其股票飆升,投資者對其獨特的商業模式和增長潛力恢復了信心。
2. $Soleno Therapeutics (SLNO.US)$: 697%
2。 $Soleno Therapeutics (SLNO.US)$: 697%
Soleno Therapeutics focuses on developing treatments for rare diseases, with a primary emphasis on genetic disorders such as Prader-Willi syndrome. The company's stock has surged due to positive clinical trial results and increased optimism about its pipeline of drug candidates.
Soleno Therapeutics專注於開發罕見疾病的治療方法,主要側重於諸如普拉德-威利綜合徵之類的遺傳性疾病。由於臨床試驗結果良好,以及對其候選藥物管道的樂觀情緒增加,該公司的股票飆升。
1. $MoneyLion (ML.US)$ 790%
1。 $MoneyLion (ML.US)$ 790%
MoneyLion Inc. is a digital financial platform offering a range of products, including personal loans, credit-building services, and financial advisory tools. Its significant stock surge is driven by aggressive expansion and innovation in fintech services, appealing to a broad customer base looking for accessible financial solutions.
MoneyLion Inc. 是一個數字金融平台,提供一系列產品,包括個人貸款、信用建設服務和財務諮詢工具。其股價大幅上漲是由金融科技服務的積極擴張和創新推動的,吸引了尋求無障礙金融解決方案的廣泛客戶群。